N. Maina

发表

Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells.

W. Shou, S. Larsen, J. Hansen, 2004, Human gene therapy.

Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model.

L. Zhong, A. Srivastava, M. Yoder, 2008, Human gene therapy.

Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics

M. Dransfield, D. Chaplin, S. Barnes, 2018, Scientific Reports.

Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.

L. Zhong, Baozheng Li, A. Srivastava, 2006, Human gene therapy.

A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.

P. Stacpoole, L. Zhong, A. Srivastava, 2008, Molecular genetics and metabolism.

Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.

S. Zolotukhin, L. Zhong, A. Rivers, 2008, Human gene therapy.

Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema

N. Maina, John Anderson, 2022, Clinical and translational allergy.

Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells.

L. Zhong, A. Srivastava, M. Yoder, 2008, Human gene therapy.

Hereditary angioedema: Comprehensive management plans and patient support.

N. Maina, John T. Anderson, D. Paige, 2020, Allergy and asthma proceedings.

Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics

M. Dransfield, D. Chaplin, S. Barnes, 2018, Scientific Reports.